Login

Financial Snapshot

Revenue
TTM
$99.77M
Gross Margin
TTM
63.97%
Net Income
TTM
-$2.961M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
729.86%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$372.2M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$2.430M

Stock Price

Loading...
Market Cap: $1.3431 Billion

About BioLife Solutions Inc

BioLife Solutions (NASDAQ: BLFS) is a life sciences tools company that develops and manufactures biopreservation media, related consumables, and bioprocessing equipment used in cell and gene therapy workflows. The filing excerpts provided in this submission do not contain sufficient detail to describe revenue breakdown by segment, customer concentration, competitive positioning, founding history, or leadership with specificity. Based solely on the excerpts available from the 10-K filed 2026-02-26 (accession 000162828026012294), a fully grounded canonical description cannot be completed without risk of introducing unsupported facts. The excerpt supplied is limited to the SEC cover page boilerplate and does not disclose financial results, segment data, product names, customer types, or geographic mix. Any further detail would rely on outside knowledge rather than the filing itself, which is excluded per sourcing rules.

Source: SEC 10-K, filed 2026-02-26

Industry: Electromedical & Electrotherapeutic Apparatus Peers: ATRION CORP Avanos Medical Inc Bioventus Inc CERUS CORP MERIDIAN BIOSCIENCE INC Pulmonx Corp OrthoPediatrics Corp Silk Road Medical Inc UFP Technologies Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support